Article
Reactive Oxygen Species and Autophagy Modulation in Non-Marine Drugs and Marine Drugs
13 Nov 2014
Abstract excerpt
It is becoming more understandable that an existing challenge for translational research is the development of pharmaceuticals that appropriately target reactive oxygen species (ROS)-mediated molecular networks in cancer cells. In line with this approach, there is an overwhelmingly increasing list of many non-marine drugs and marine drugs reported to be involved in inhibiting and suppressing cancer progression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
